Institutional Ownership Crinetics Pharmaceuticals, Inc. (CRNX)
This table provides information about the institutional ownership of Crinetics Pharmaceuticals, Inc. (CRNX). We have compiled data on the 254 institutions that hold shares in the stock, with a total of 89.2 Million shares, which have been reported (via 13F filing form) to have a value of $3.29 Billion.
Holding | Report Date | shares Held | Holding Value (Reported) | Last Trade | Trade History |
---|---|---|---|---|---|
Vanguard Group Inc
Valley Forge, PA |
Feb 11, 2025 Q4 2024 |
9,089,391
shares
|
$335 Million
0.01% of portfolio
|
Q4 2024
Added 44.56%
|
|
Wellington Management Group LLP
Boston, MA |
Feb 12, 2025 Q4 2024 |
6,950,567
shares
|
$256 Million
0.07% of portfolio
|
Q4 2024
Added 55.85%
|
|
Black Rock Inc.
New York, NY |
Aug 13, 2024 Q2 2024 |
6,230,371
shares
|
$230 Million
0.01% of portfolio
|
Q2 2024
Added 14.61%
|
|
Driehaus Capital Management LLC
Chicago, IL |
Feb 14, 2025 Q4 2024 |
6,141,014
shares
|
$226 Million
3.06% of portfolio
|
Q4 2024
Added 4.35%
|
|
Price T Rowe Associates Inc
Baltimore, MD |
Feb 14, 2025 Q4 2024 |
5,414,505
shares
|
$200 Million
0.03% of portfolio
|
Q4 2024
Added 9.5%
|
|
Eco R1 Capital, LLC
San Francisco, CA |
Feb 14, 2025 Q4 2024 |
4,288,120
shares
|
$158 Million
10.24% of portfolio
|
Q3 2024
Added 3.19%
|
|
Farallon Capital Management LLC
San Francisco, CA |
Feb 14, 2025 Q4 2024 |
4,075,098
shares
|
$150 Million
1.11% of portfolio
|
Q4 2024
Added 250.7%
|
|
State Street Corp
Boston, MA |
Feb 14, 2025 Q4 2024 |
2,990,838
shares
|
$110 Million
0.01% of portfolio
|
Q4 2024
Added 5.37%
|
|
Janus Henderson Group PLC
London, X0 |
Feb 14, 2025 Q4 2024 |
2,795,441
shares
|
$103 Million
0.08% of portfolio
|
Q4 2024
Added 15.06%
|
|
Steven Cohen
Point72 Asset Management, L.P. | Stamford, Ct
|
Feb 14, 2025 Q4 2024 |
2,788,939
shares
|
$103 Million
0.34% of portfolio
|
Q4 2024
Added 21.22%
|
|
Jennison Associates LLC
|
Jan 24, 2025 Q4 2024 |
2,708,351
shares
|
$99.8 Million
0.09% of portfolio
|
Q4 2024
Reduced 3.05%
|
|
Geode Capital Management, LLC
Boston, MA |
Feb 12, 2025 Q4 2024 |
2,098,841
shares
|
$77.4 Million
0.01% of portfolio
|
Q4 2024
Added 13.57%
|
|
Paradigm Biocapital Advisors LP
New York, NY |
Feb 14, 2025 Q4 2024 |
1,910,761
shares
|
$70.4 Million
3.73% of portfolio
|
Q4 2024
Reduced 24.08%
|
|
Siren, L.L.C.
New York, NY |
Feb 14, 2025 Q4 2024 |
1,609,652
shares
|
$59.3 Million
3.64% of portfolio
|
Q4 2024
Added 22.91%
|
|
Franklin Resources Inc
San Mateo, CA |
Feb 12, 2025 Q4 2024 |
1,591,666
shares
|
$58.7 Million
0.02% of portfolio
|
Q4 2024
Added 14.5%
|
|
T. Rowe Price Investment Management, Inc.
Baltimore, MD |
Feb 14, 2025 Q4 2024 |
1,002,882
shares
|
$37 Million
0.03% of portfolio
|
Q4 2024
Reduced 6.14%
|
|
Cormorant Asset Management, LP
Boston, MA |
Feb 14, 2025 Q4 2024 |
1,000,000
shares
|
$36.9 Million
4.04% of portfolio
|
Q4 2024
Reduced 9.09%
|
|
Orbimed Advisors LLC
San Diego, CA |
Feb 14, 2025 Q4 2024 |
999,000
shares
|
$36.8 Million
1.38% of portfolio
|
Q4 2024
Reduced 4.86%
|
|
Novo Holdings
Hellerup, G7 |
Feb 14, 2025 Q4 2024 |
960,215
shares
|
$35.4 Million
3.99% of portfolio
|
Q4 2024
Reduced 3.98%
|
|
First Light Asset Management, LLC
Edina, MN |
Feb 14, 2025 Q4 2024 |
885,453
shares
|
$32.6 Million
4.43% of portfolio
|
Q4 2024
Reduced 6.16%
|
|
Northern Trust Corp
Chicago, IL |
Feb 14, 2025 Q4 2024 |
879,814
shares
|
$32.4 Million
0.01% of portfolio
|
Q4 2024
Added 20.44%
|
|
Hood River Capital Management LLC
Palm Beach Gardens, FL |
Feb 14, 2025 Q4 2024 |
851,400
shares
|
$31.4 Million
0.75% of portfolio
|
Q4 2024
Added 1.97%
|
|
Pictet Asset Management Holding Sa
Carouge, V8 |
Feb 12, 2025 Q4 2024 |
848,050
shares
|
$31.3 Million
0.05% of portfolio
|
Q4 2024
Reduced 6.62%
|
|
Charles Schwab Investment Management Inc
San Francisco, CA |
Feb 06, 2025 Q4 2024 |
759,126
shares
|
$28 Million
0.01% of portfolio
|
Q4 2024
Added 15.82%
|
|
Lord, Abbett & Co. LLC
Jersey City, NJ |
Feb 14, 2025 Q4 2024 |
724,625
shares
|
$26.7 Million
0.12% of portfolio
|
Q4 2024
Reduced 2.88%
|